L
Leah Lipsich
Researcher at Regeneron
Publications - 24
Citations - 2492
Leah Lipsich is an academic researcher from Regeneron. The author has contributed to research in topics: Placebo & Viral load. The author has an hindex of 11, co-authored 20 publications receiving 1037 citations.
Papers
More filters
Journal ArticleDOI
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19.
David M. Weinreich,Sumathi Sivapalasingam,Thomas Norton,Shazia Ali,Haitao Gao,Rafia Bhore,Bret J Musser,Yuhwen Soo,Diana Rofail,Joseph Im,Christina Perry,Cynthia Pan,Romana Hosain,Adnan Mahmood,John D. Davis,Kenneth C. Turner,Andrea T. Hooper,Jennifer D. Hamilton,Alina Baum,Christos A. Kyratsous,Yunji Kim,Amanda Cook,Wendy Kampman,Anita Kohli,Yessica Sachdeva,Ximena Graber,Bari Kowal,Thomas DiCioccio,Neil Stahl,Leah Lipsich,Ned Braunstein,Gary Herman,George D. Yancopoulos +32 more
TL;DR: In this interim analysis, the REGN-COV2 antibody cocktail reduced viral load, with a greater effect in patients whose immune response had not yet been initiated or who had a high viral load at baseline.
Journal ArticleDOI
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.
Meagan P. O'Brien,Eduardo Forleo-Neto,Bret J Musser,Flonza Isa,Kuo-Chen Chan,Neena Sarkar,Katharine J. Bar,Ruanne V. Barnabas,Dan H. Barouch,Myron S. Cohen,Christopher B. Hurt,Dale R. Burwen,Mary A. Marovich,Peijie Hou,Ingeborg Heirman,John D. Davis,Kenneth C. Turner,Divya Ramesh,Adnan Mahmood,Andrea T. Hooper,Jennifer D. Hamilton,Yunji Kim,Lisa A. Purcell,Alina Baum,Christos A. Kyratsous,James Krainson,Richard Perez-Perez,Rizwana Mohseni,Bari Kowal,A. Thomas DiCioccio,Neil Stahl,Leah Lipsich,Ned Braunstein,G. Herman,George D. Yancopoulos,David M. Weinreich +35 more
TL;DR: The combination of the monoclonal antibodies casirivimab and imdevimab has been shown to markedly reduce the risk of hospitalization or... as discussed by the authors, which is known as REGN-COV2.
Journal ArticleDOI
Treating cat allergy with monoclonal IgG antibodies that bind allergen and prevent IgE engagement.
Jamie M. Orengo,Allen Radin,Vishal Kamat,Ashok Badithe,Li-Hong Ben,Brandy L. Bennett,S. Zhong,Dylan Birchard,Andre Limnander,Ashique Rafique,Joannie Bautista,Aleksandar Kostic,D. Newell,Xunbao Duan,Matthew C. Franklin,William C. Olson,Tammy T. Huang,Namita Gandhi,Leah Lipsich,N. Stahl,Nicholas J. Papadopoulos,A.J. Murphy,George D. Yancopoulos +22 more
TL;DR: It is suggested that simply augmenting the blocking IgG/IgE ratio may reverse allergy, and the administration of two cat allergen-specific IgGs reduces allergic responses in mouse models and helps ameliorate clinical symptoms in a phase 1b clinical trial.
Journal ArticleDOI
The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.
Richard Copin,Alina Baum,Elzbieta Wloga,Kristen E. Pascal,Stephanie Giordano,Benjamin O. Fulton,Anbo Zhou,Nicole Negron,Kathryn Lanza,Newton Chan,Angel Coppola,Joyce Chiu,Min Ni,Yi Wei,Gurinder S. Atwal,Annabel Romero Hernandez,Kei Saotome,Yi Zhou,Matthew C. Franklin,Andrea T. Hooper,Shane McCarthy,Sara Hamon,Jennifer D. Hamilton,Hilary M. Staples,Kendra J. Alfson,Ricardo Carrion,Shazia Ali,Thomas Norton,Selin Somersan-Karakaya,Sumathi Sivapalasingam,Gary Herman,David M. Weinreich,Leah Lipsich,Neil Stahl,Andrew J. Murphy,George D. Yancopoulos,Christos A. Kyratsous +36 more
TL;DR: In this paper, the sequence diversity of the spike protein and monitored emergence of virus variants in SARS-CoV-2 isolates found in COVID-19 patients treated with the two-antibody combination REGEN-COV, as well as in preclinical in vitro studies using single, dual, or triple antibody combinations.
Journal ArticleDOI
Development of Clinical-Stage Human Monoclonal Antibodies That Treat Advanced Ebola Virus Disease in Nonhuman Primates.
Kristen E. Pascal,Drew Dudgeon,John C. Trefry,Manu Anantpadma,Yasuteru Sakurai,Charles D. Murin,Hannah L. Turner,Jeanette L. Fairhurst,Marcela Torres,Ashique Rafique,Ying Yan,Ashok Badithe,Kevin Yu,Terra Potocky,Sandra L. Bixler,Taylor B. Chance,William D. Pratt,Franco Rossi,Joshua D. Shamblin,Suzanne E. Wollen,Justine M. Zelko,Ricardo Carrion,Gabriella Worwa,Hilary M. Staples,Darya Burakov,Robert Babb,Gang Chen,Joel H. Martin,Tammy T. Huang,Karl J. Erlandson,Melissa S Willis,Kimberly Armstrong,Thomas M Dreier,Andrew B. Ward,Robert A. Davey,Margaret L. Pitt,Leah Lipsich,Peter W. Mason,William C. Olson,Neil Stahl,Christos A. Kyratsous +40 more
TL;DR: A single dose of a cocktail of the 3 antibodies protected nonhuman primates (NHPs) from EBOV disease even after disease symptoms were apparent, and demonstrates high-level postexposure protection from lethal E BOV disease in NHPs.